Sign In
Buy ABT
$100.79
+0.200 (+0.199%)
At Close: Jul 23, 2026
Arizona State Retirement System Sells 13,152 Shares of Abbott Laboratories $ABT
03:48am, Friday, 24'th Apr 2026
Arizona State Retirement System lowered its stake in Abbott Laboratories (NYSE: ABT) by 2.6% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Comm
Eagleford Energy (OTCMKTS:GRUSF) and Abbott Laboratories (NYSE:ABT) Head to Head Review
02:31am, Friday, 24'th Apr 2026
Eagleford Energy (OTCMKTS:GRUSF - Get Free Report) and Abbott Laboratories (NYSE: ABT - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
10:01am, Wednesday, 22'nd Apr 2026
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Abbott Laboratories Just Got Interesting: Dividend Yield Near 3% Signals Opportunity
12:20pm, Tuesday, 21'st Apr 2026
Abbott Laboratories (ABT) offers a 2.5% dividend yield, over 50 years of increases, and trades at a forward P/E below its 5-year average. Recent post-earnings sell-off, driven by lowered EPS guidance
Wall Street Refuses to Blink: 2 Healthcare Stocks at 52-Week Lows That Analysts Still Love
11:20am, Tuesday, 21'st Apr 2026
Boston Scientific (NYSE: BSX) trades around $61, with analyst price targets ranging from $69 (conservative) to $124 (optimistic), implying substantial upside.
Is the Options Market Predicting a Spike in Abbott Laboratories Stock?
09:56am, Tuesday, 21'st Apr 2026
Investors need to pay close attention to ABT stock based on the movements in the options market lately.
Abbott Laboratories: Buy The Dip On This Dividend King
08:00am, Tuesday, 21'st Apr 2026
Abbott Laboratories presents a compelling buy-the-dip opportunity, as short-term headwinds and conservative guidance overshadow its durable, diversified growth platform. ABT's diversified healthcare p
Finivi Inc. Sells 5,434 Shares of Abbott Laboratories $ABT
04:36am, Tuesday, 21'st Apr 2026
Finivi Inc. decreased its position in Abbott Laboratories (NYSE: ABT) by 71.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission
Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom
04:21pm, Monday, 20'th Apr 2026
Abbott Laboratories and Dexcom are the biggest players in the market for continuous glucose monitoring devices. Abbott has a vast lineup of products beyond that and an overall diversified healthcare b
ABT Fairly Valued by DCF at $93
07:36am, Monday, 20'th Apr 2026
On April 20, 2026, we delve into the DCF analysis for Abbott Laboratories (ABT), a company that has faced significant price performance challenges recently, wit
Has the Abbott Laboratories Sell-Off Finally Created an Entry Point?
07:05am, Monday, 20'th Apr 2026
Whether Abbott Laboratories (NYSE: ABT | ABT Price Prediction) stock is at a good entry point depends on your investment horizon and tolerance for near-term uncertainty.
Market Crash: 2 Healthcare Stocks Worth Loading Up on at a Discount
05:08am, Monday, 20'th Apr 2026
These healthcare stocks offer long track records of solid performance. They declined with the general market in recent times, offering savvy long-term investors a fresh buying opportunity.
Abbott Laboratories $ABT Shares Sold by Lbp Am Sa
04:37am, Saturday, 18'th Apr 2026
Lbp Am Sa decreased its position in Abbott Laboratories (NYSE: ABT) by 67.0% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commi
Abbott Laboratories Q1 Earnings Call Highlights
01:05am, Saturday, 18'th Apr 2026
Abbott Laboratories (NYSE: ABT) reported first-quarter 2026 results that management said were "aligned with our expectations for the start of the year," as the company absorbed weaker respiratory test
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
03:30pm, Friday, 17'th Apr 2026
Data show how a multi-biomarker class approach improves early-stage cancer detection AACR will also recognize landmark DETECT-A study publication reporting long-term outcomes supporting the clinical i
